Overview

A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) Catheters

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This was a Phase III, open-label study conducted at 44 centers in the United States, Canada, and Puerto Rico. 223 subjects who required hemodialysis (HD) and had a dysfunctional HD catheter were enrolled in the study.
Phase:
Phase 3
Details
Lead Sponsor:
Genentech, Inc.
Treatments:
Tenecteplase
Tissue Plasminogen Activator